GSK has acquired RAPT Therapeutics
Further information can be found in the latest press release.
COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES
RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
« back to news page
You are leaving RAPT.com to go to the eczema clinical trial study site.
